Calidi Biotherapeutics and Nova Minerals Feature on Bloomberg TV

RedChip Companies will present interviews with Calidi Biotherapeutics, Inc. and Nova Minerals Limited on Bloomberg TV's RedChip Small Stocks, Big Money™ show this Saturday, December 6, at 7 p.m. Eastern Time. Viewers can access complete interviews online. Calidi Biotherapeutics' CEO, Eric Poma, will discuss the company's innovative RedTail platform, designed to target metastatic tumors with precision genetic medicine. This technology positions Calidi in the oncology market, projected to surpass $560 billion by 2033. Calidi plans to file an IND by the end of 2026, bolstered by a robust business model and a promising pipeline.

Nova Minerals' CEO, Christopher Gerteisen, will detail plans for the Estelle Project in Alaska, an emerging critical minerals site. The project spans 514 km², hosting major gold and antimony prospects. Nova's dual strategy aims to establish a U.S. antimony supply chain and accelerate gold production. Supported by a $43.4 million award from the U.S. Department of War, Nova is advancing its feasibility study and industry collaborations. The company's efforts aim to secure its role as a key supplier in North America.